Wolff Wiese Magana LLC Takeda Pharmaceutical CO LTD Transaction History

Wolff Wiese Magana LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$12.8 - $28.65 $7,923 - $17,734	-619 Reduced 61.35%	390 $5,000
Q4 2021 Jan 18, 2022	SELL	$13.17 - $16.4 $5,044 - $6,281	-383 Reduced 27.51%	1,009 $14,000
Q3 2021 Oct 15, 2021	BUY	$16.3 - $17.26 $6,357 - $6,731	390 Added 38.92%	1,392 $23,000
Q2 2021 Jul 15, 2021	BUY	$16.55 - $18.64 $1,655 - $1,864	100 Added 11.09%	1,002 $17,000
Q1 2021 Apr 15, 2021	BUY	$16.71 - $19.9 $1,219 - $1,452	73 Added 8.81%	902 $16,000
Q4 2020 Jan 27, 2021	BUY	$15.39 - $18.97 $12,758 - $15,726	829 New	829 $15,000

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

Stay updated on Wolff Wiese Magana LLC with notifications on news.